#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer recurrent Germ cell cancer Heritable pulmonary arterial hypertension Leber's congenital amaurosis Neurotrophic keratopathy Fibrosarcoma Hypotransferrinaemia Eosinophilic granulomatosis with polyangiitis Glomerulonephritis rapidly progressive Prolymphocytic leukaemia Microvillous inclusion disease Huntington's disease Chondrosarcoma Kearns-Sayre syndrome Mucopolysaccharidosis II More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Diagnostics Isodicentric chromosome 15 syndrome Thrombotic thrombocytopenic purpura – Treatment Haemophagocytic lymphohistiocytosis Hairy cell leukaemia recurrent – Diagnostics Brain stem glioma – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Alagille syndrome – Basic Information Gaucher’s disease type I – Basic Information Fragile X syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Medi0618 Keto-Valine Calcium Promethazine Hydrochloride Rbl012.2 Human Cancellous Bone Afamelanotide Ketoprofen Oditrasertib Clic-1901 Cart Magnesium Denosumab Zilucoplan Sodium Heterodimeric Interleukin-15 Bcmacp03 Festuca Elatior Pollen Extract Betamethasone Acetate Thiopental Sodium Hydroxycarbamide VMX-C001 Glucose Monohydrate More therapies…

    Learn about Your Condition

    Urethral stenosis Post procedural oedema Bone hypertrophy Neuroendocrine tumour Ocular lymphoma Actinic keratosis Mucopolysaccharidosis I Oedema Hepatic cancer Enteritis Bladder cancer Mucosal inflammation Nodal osteoarthritis Hypertension Exudative retinopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Alirocumab and Drug Combination on Hyperlipidemia in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperlipidaemia
    Investigated Drugs:
    • Alirocumab
    • Evolocumab
    • Rosuvastatin Zinc
    Austria

  • Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    Italy

  • Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma recurrent
    • Extra-osseous Ewing’s sarcoma
    • Extra-osseous Ewing’s sarcoma metastatic
    Investigated Drugs:
    • Topotecan
    • Etoposide Phosphate
    • Anhydrous Docetaxel
    Austria Belgium Czechia Denmark Finland France +4

  • Study on Efgartigimod for Early Treatment in Patients with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    Spain

  • Study of RR001 with Gemcitabine and Paclitaxel for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Autologous Human Adipose Perivascular Stromal Cells Genetically Modified To Secrete Soluble Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Italy

  • Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Niraparib
    Belgium Czechia Germany Italy
Previous Page
1 … 300 301 302 303 304 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!